Viewing StudyNCT05929885



Ignite Creation Date: 2024-05-06 @ 7:10 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05929885
Status: RECRUITING
Last Update Posted: 2024-01-03
First Post: 2023-04-24

Brief Title: Metronomic Capecitabine Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
Sponsor: National Cancer Centre Singapore
Organization: National Cancer Centre Singapore

Conditions & Keywords Data

Conditions:
Name
Metastatic Pancreatic Cancer
Keywords:
Name View
UGT1A1 View
Low Dose OXIRI LDOXIRI View
Pancreatic Cancer View
Irinotecan View
Oxaliplatin View
Capecitabine View
Pharmacokinetics View
Metronomic Chemotherapy View